Improved third-generation lentiviral packaging with pLKO.1C vectors.


Journal

BioTechniques
ISSN: 1940-9818
Titre abrégé: Biotechniques
Pays: England
ID NLM: 8306785

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 7 3 2020
medline: 1 9 2021
entrez: 7 3 2020
Statut: ppublish

Résumé

A widely used third-generation lentiviral packaging system produces virus with enhanced biosafety by eliminating HIV accessory genes and separating packaging elements into three different plasmids. However, for certain vectors such as pLKO.1, third-generation safety features reduce lentiviral titers due to the lack of the accessory gene

Identifiants

pubmed: 32141762
doi: 10.2144/btn-2019-0155
pmc: PMC7333533
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

349-352

Subventions

Organisme : NCI NIH HHS
ID : R01 CA137124
Pays : United States

Références

J Virol. 1999 Mar;73(3):1828-34
pubmed: 9971760
Nature. 2014 Oct 16;514(7522):385-8
pubmed: 25252974
Mol Biol Int. 2012;2012:614120
pubmed: 22701796
Gene Ther. 1995 Jun;2(4):269-78
pubmed: 7552987
J Virol. 1998 Nov;72(11):8463-71
pubmed: 9765382
Nature. 1987 Dec 3-9;330(6147):489-93
pubmed: 2825027
Nat Methods. 2006 Sep;3(9):715-9
pubmed: 16929317
Nat Biotechnol. 2005 Jan;23(1):108-16
pubmed: 15619618
J Virol. 1998 Oct;72(10):8150-7
pubmed: 9733856
Science. 1996 Apr 12;272(5259):263-7
pubmed: 8602510
J Virol. 1998 Jan;72(1):811-6
pubmed: 9420292
Nat Genet. 2000 Jun;25(2):217-22
pubmed: 10835641
Nat Biotechnol. 1997 Sep;15(9):871-5
pubmed: 9306402
Hum Gene Ther. 2000 Nov 20;11(17):2403-13
pubmed: 11096444
PLoS One. 2010 May 12;5(5):e10611
pubmed: 20485554
Cell. 2006 Mar 24;124(6):1283-98
pubmed: 16564017
Cell. 1985 Jun;41(2):521-30
pubmed: 2985280
Science. 2016 Sep 9;353(6304):1101-2
pubmed: 27609877
BMC Biotechnol. 2013 Nov 12;13:98
pubmed: 24215295
J Virol. 1998 Dec;72(12):9873-80
pubmed: 9811723

Auteurs

Sunhye Lee (S)

The Vision Center, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.

David Cobrinik (D)

The Vision Center, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
Roski Eye Institute & Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.
Department of Biochemistry & Molecular Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.
Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH